Evidence map›Paper›PMID 34721276›Full record

ArticleFrontiers in neurology2021

Radiological and Laboratory Features of Multiple Sclerosis Patients With Immunosuppressive Therapy: A Multicenter Retrospective Study in Japan.

Shinji Ashida, Hirofumi Ochi, Mio Hamatani, Chihiro Fujii, Ryusei Nishigori, Kazuyuki Kawamura, Sadayuki Matsumoto, Masanori Nakagawa, Ryosuke Takahashi, Toshiki Mizuno and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 1 country.

Shinji AshidaDepartment of Neurology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Hirofumi OchiDepartment of Neurology and Geriatric Medicine, Ehime University Graduate School of Medicine, Ehime, Japan.
Mio HamataniDepartment of Neurology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Chihiro FujiiDepartment of Neurology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Ryusei NishigoriDepartment of Neurology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Kazuyuki KawamuraDepartment of Neurology, National Hospital Organization Minami Kyoto Hospital, Kyoto, Japan.
Sadayuki MatsumotoDepartment of Neurology, Kitano Hospital, Osaka, Japan.
Masanori NakagawaDepartment of Neurology, North Medical Center Kyoto Prefectural University of Medicine, Kyoto, Japan.
Ryosuke TakahashiDepartment of Neurology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Toshiki MizunoDepartment of Neurology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Takayuki KondoDepartment of Neurology, Kansai Medical University Medical Center, Osaka, Japan.
Kyoto Prefectural University of Medicine · JPKyoto University · JPEhime University · JPKansai Medical University · JPKitano Hospital · JPKyoto Medical Center · JPNorth Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

immunosuppressantMRImultiple sclerosisserum autoantibodiestreatment

Identifiers

PMID34721276
PMCPMC8548818
OpenAlexW3205936575

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.